Outcomes of early parenteral nutrition for premature infants

J Trintis1, P Donohue, S Aucott

  • 1Division of Neonatology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Insights

Early amino acid (AA) administration in very low birth weight (VLBW) infants showed similar efficacy to standard nutrition. However, increased necrotizing enterocolitis (NEC) was observed with early AA, potentially impacting growth.

Area of Science:

  • Neonatal nutrition
  • Pediatric gastroenterology
  • Clinical research

Background:

  • Parenteral nutrition (PN) is crucial for very low birth weight (VLBW) infants.
  • Optimizing nutrient delivery, including amino acids (AA), is essential for VLBW infant outcomes.
  • Early AA administration strategies require safety and efficacy evaluation.

Purpose of the Study:

  • To assess the safety and efficacy of early amino acid (AA) administration in very low birth weight (VLBW) infants.
  • To compare clinical outcomes between early AA and standard parenteral nutrition (PN) protocols.

Main Methods:

  • A pre- and post-intervention study design was employed.
  • Clinical data were collected for VLBW infants before and after implementing an early AA protocol.
  • Outcomes included mortality, time to regain birth weight, enteral feeding initiation and achievement, and growth parameters.

Main Results:

  • No significant differences were observed in mortality, time to regain birth weight, feeding milestones, or weight at 32 weeks post-menstrual age between groups.
  • Incidence of late sepsis, direct hyperbilirubinemia, and chronic lung disease did not differ.
  • Necrotizing enterocolitis (NEC) occurred significantly more frequently in the early AA group (12% vs 1%, P=0.012).

Conclusions:

  • Early AA administration in VLBW infants demonstrated comparable efficacy to standard PN therapy.
  • The increased incidence of NEC in the early AA group suggests a potential negative impact on growth and nutrition.
  • Further research is needed to balance the benefits and risks of early AA supplementation in VLBW infants.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...